Cargando…

The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations

CONTEXT: Pain management in cirrhotic patients is a major clinical challenge for medical professionals. Unfortunately there are no concrete guidelines available regarding the administration of analgesics in patients with liver cirrhosis. In this review we aimed to summarize the available literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Imani, Farnad, Motavaf, Mahsa, Safari, Saeid, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250965/
https://www.ncbi.nlm.nih.gov/pubmed/25477978
http://dx.doi.org/10.5812/hepatmon.23539
_version_ 1782346976523714560
author Imani, Farnad
Motavaf, Mahsa
Safari, Saeid
Alavian, Seyed Moayed
author_facet Imani, Farnad
Motavaf, Mahsa
Safari, Saeid
Alavian, Seyed Moayed
author_sort Imani, Farnad
collection PubMed
description CONTEXT: Pain management in cirrhotic patients is a major clinical challenge for medical professionals. Unfortunately there are no concrete guidelines available regarding the administration of analgesics in patients with liver cirrhosis. In this review we aimed to summarize the available literature and suggest appropriate evidence-based recommendations regarding to administration of these drugs. EVIDENCE ACQUISITION: An indexed MEDLINE search was conducted in July 2014, using keywords “analgesics”, “hepatic impairment”, “cirrhosis”, “acetaminophen or paracetamol”, “NSAIDs or nonsteroidal anti-inflammatory drugs”, “opioid” for the period of 2004 to 2014. All randomized clinical trials, case series, case report and meta-analysis studies with the above mentioned contents were included in review process. In addition, unpublished information from the Food and Drug Administration are included as well. RESULTS: Paracetamol is safe in patients with chronic liver disease but a reduced dose of 2-3 g/d is recommended for long-term use. Non-steroidal anti-inflammatory drugs (NSAIDs) are best avoided because of risk of renal impairment, hepatorenal syndrome, and gastrointestinal hemorrhage. Most opioids can have deleterious effects in patients with cirrhosis. They have an increased risk of toxicity and hepatic encephalopathy. They should be administrated with lower and less frequent dosing in these patients and be avoided in patients with a history of encephalopathy or addiction to any substance. CONCLUSIONS: No evidence-based guidelines exist on the use of analgesics in patients with liver disease and cirrhosis. As a result pain management in these patients generates considerable misconception among health care professionals, leading under-treatment of pain in this population. Providing concrete guidelines toward the administration of these agents will lead to more efficient and safer pain management in this setting.
format Online
Article
Text
id pubmed-4250965
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-42509652014-12-04 The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations Imani, Farnad Motavaf, Mahsa Safari, Saeid Alavian, Seyed Moayed Hepat Mon Review Article CONTEXT: Pain management in cirrhotic patients is a major clinical challenge for medical professionals. Unfortunately there are no concrete guidelines available regarding the administration of analgesics in patients with liver cirrhosis. In this review we aimed to summarize the available literature and suggest appropriate evidence-based recommendations regarding to administration of these drugs. EVIDENCE ACQUISITION: An indexed MEDLINE search was conducted in July 2014, using keywords “analgesics”, “hepatic impairment”, “cirrhosis”, “acetaminophen or paracetamol”, “NSAIDs or nonsteroidal anti-inflammatory drugs”, “opioid” for the period of 2004 to 2014. All randomized clinical trials, case series, case report and meta-analysis studies with the above mentioned contents were included in review process. In addition, unpublished information from the Food and Drug Administration are included as well. RESULTS: Paracetamol is safe in patients with chronic liver disease but a reduced dose of 2-3 g/d is recommended for long-term use. Non-steroidal anti-inflammatory drugs (NSAIDs) are best avoided because of risk of renal impairment, hepatorenal syndrome, and gastrointestinal hemorrhage. Most opioids can have deleterious effects in patients with cirrhosis. They have an increased risk of toxicity and hepatic encephalopathy. They should be administrated with lower and less frequent dosing in these patients and be avoided in patients with a history of encephalopathy or addiction to any substance. CONCLUSIONS: No evidence-based guidelines exist on the use of analgesics in patients with liver disease and cirrhosis. As a result pain management in these patients generates considerable misconception among health care professionals, leading under-treatment of pain in this population. Providing concrete guidelines toward the administration of these agents will lead to more efficient and safer pain management in this setting. Kowsar 2014-10-11 /pmc/articles/PMC4250965/ /pubmed/25477978 http://dx.doi.org/10.5812/hepatmon.23539 Text en Copyright © 2014, Kowsar.; Published by Kowsar. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Review Article
Imani, Farnad
Motavaf, Mahsa
Safari, Saeid
Alavian, Seyed Moayed
The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title_full The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title_fullStr The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title_full_unstemmed The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title_short The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
title_sort therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250965/
https://www.ncbi.nlm.nih.gov/pubmed/25477978
http://dx.doi.org/10.5812/hepatmon.23539
work_keys_str_mv AT imanifarnad thetherapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT motavafmahsa thetherapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT safarisaeid thetherapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT alavianseyedmoayed thetherapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT imanifarnad therapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT motavafmahsa therapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT safarisaeid therapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations
AT alavianseyedmoayed therapeuticuseofanalgesicsinpatientswithlivercirrhosisaliteraturereviewandevidencebasedrecommendations